Novo Nordisk drops about 2% as Wegovy launches in Germany
Novo Nordisk fell about 2% to $46.625 on Friday as Wegovy’s once-daily oral pill rollout reached its first EU market, with Germany joining markets that already sell the treatment.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.